
US approves updated Covid vaccines to rev up protection this fall
The Food and Drug Administration decision opens the newest shots from Moderna and Pfizer and its partner BioNTech to most Americans even if they’ve never had a coronavirus vaccination
The Food and Drug Administration decision opens the newest shots from Moderna and Pfizer and its partner BioNTech to most Americans even if they’ve never had a coronavirus vaccination
European countries are negotiating with pharmaceutical companies to avoid accumulating unused doses
Research and development expenses nearly doubled to $1.2 billion for the drugmaker
The study found that combining mRNA technology with a cancer drug reduces the risk of recurrence or death by 44%
The company accuses its competitors of copying its messenger RNA technology without its permission